Celgene Corporation

Organization

Summit, NJ, US

Ticker Symbols

NASDAQ:CELG

NASDAQ:CELGZ

PHARMACEUTICAL PREPARATIONS
Business Address
86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
Mailing Address
86 MORRIS AVENUE SUMMIT NJ 07901
State Location
NJ
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Transgenic mouse expressing human cereblon
- Patent number 11,963,520
- Issue date Apr 23, 2024
- Celgene Corporation
- Rajesh Chopra
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Substituted 4-aminoisoindoline-1,3-dione compounds, compositions th...
- Patent number 11,945,804
- Issue date Apr 2, 2024
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapies using an anti-BCMA antibody drug conjugate (A...
- Patent number 11,931,420
- Issue date Mar 19, 2024
- Celgene Corporation
- Kaida Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carboxylic acid containing azetidinyl compounds for the treatment o...
- Patent number 11,919,879
- Issue date Mar 5, 2024
- Celgene Corporation
- Jeffrey M. Schkeryantz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxope...
- Patent number 11,912,644
- Issue date Feb 27, 2024
- Celgene Corporation
- John F. Traverse
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formulations of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)...
- Patent number 11,883,389
- Issue date Jan 30, 2024
- Celgene Corporation
- Ho-Wah Hui
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds,...
- Patent number 11,873,283
- Issue date Jan 16, 2024
- Celgene Corporation
- Massimo Ammirante
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dio...
- Patent number 11,866,417
- Issue date Jan 9, 2024
- Celgene Corporation
- Jerry Lee Atwood
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
T lymphocyte production methods and t lymphocytes produced thereby
- Patent number 11,834,675
- Issue date Dec 5, 2023
- Celgene Corporation
- Bitao Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified T lymphocytes comprising a CD52 antibody-inducible caspase...
- Patent number 11,806,365
- Issue date Nov 7, 2023
- Celgene Corporation
- Stewart Abbot
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-CD47 antibodies and uses thereof
- Patent number 11,787,860
- Issue date Oct 17, 2023
- Celgene Corporation
- Aaron Sato
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxo...
- Patent number 11,779,580
- Issue date Oct 10, 2023
- Celgene Corporation
- Anjali Agrawal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of synthesis of (1R,2R,5R)-5-amino-2-methyl-cyclohexanol hy...
- Patent number 11,780,801
- Issue date Oct 10, 2023
- Celgene Corporation
- Terrence Joseph Connolly
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoiso...
- Patent number RE49647
- Issue date Sep 12, 2023
- Celgene Corporation
- Darshan Parikh
Information Patent Grant
Cereblon binding compounds, compositions thereof, and methods of tr...
- Patent number 11,739,075
- Issue date Aug 29, 2023
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for inducing conformational changes in cer...
- Patent number 11,733,233
- Issue date Aug 22, 2023
- Celgene Corporation
- Brian E. Cathers
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for treating multiple myeloma and the use of companion biom...
- Patent number 11,726,080
- Issue date Aug 15, 2023
- Celgene Corporation
- Maria Soraya Carrancio Anton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-...
- Patent number 11,701,362
- Issue date Jul 18, 2023
- Celgene Corporation
- Scott Bone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromet...
- Patent number 11,680,046
- Issue date Jun 20, 2023
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating hematological malignancies using 2-(2,6-dioxopi...
- Patent number 11,666,579
- Issue date Jun 6, 2023
- Celgene Corporation
- Maria Soraya Carrancio Anton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiproliferative compounds and second active agents for combined use
- Patent number 11,660,297
- Issue date May 30, 2023
- Celgene Corporation
- Lilly L. Wong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperi...
- Patent number 11,660,302
- Issue date May 30, 2023
- Celgene Corporation
- Peter H. Schafer
- G01 - MEASURING TESTING
Information Patent Grant
Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-pi...
- Patent number 11,655,232
- Issue date May 23, 2023
- Celgene Corporation
- Markian S. Jaworsky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for measuring small molecule affinity to cereblon
- Patent number 11,644,461
- Issue date May 9, 2023
- Celgene Corporation
- Philip Paul Chamberlain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cereblon binding compounds, compositions thereof, and methods of tr...
- Patent number 11,634,407
- Issue date Apr 25, 2023
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating chronic lymphocytic leukemia using 2-(2,6-dioxo...
- Patent number 11,628,172
- Issue date Apr 18, 2023
- Celgene Corporation
- Preethi Janardhanan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of improving vector transduction efficiency into T lymphocytes
- Patent number 11,629,335
- Issue date Apr 18, 2023
- Celgene Corporation
- Bitao Liang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Digital health prognostic analyzer for multiple myeloma mortality p...
- Patent number 11,626,210
- Issue date Apr 11, 2023
- Celgene Corporation
- Shankar Swamimalai Srinivasan
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
SIRP-α binding proteins and methods of use thereof
- Patent number 11,591,390
- Issue date Feb 28, 2023
- Celgene Corporation
- Mahan Abbasian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2...
- Patent number 11,590,117
- Issue date Feb 28, 2023
- Celgene Corporation
- Soraya Carrancio
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS A...
- Publication number 20240148744
- Publication date May 9, 2024
- Celgene Corporation
- Natalie Hawryluk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for Treating Multiple Myeloma
- Publication number 20240132623
- Publication date Apr 25, 2024
- Celgene Corporation
- Nicholas Stong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Carboxylic Acid Containing Indanyl Compounds for the Treatment of N...
- Publication number 20240124394
- Publication date Apr 18, 2024
- Celgene Corporation
- Jeffrey M. Schkeryantz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heterocyclic Compounds and Their Use for Parasitic Diseases
- Publication number 20240124444
- Publication date Apr 18, 2024
- Celgene Corporation
- Dale E. Robinson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaryl Compounds as Ligand Directed Degraders of IRAK4
- Publication number 20240109881
- Publication date Apr 4, 2024
- Bristol-Myers Squibb Company
- Timothy Rasmusson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR REDUCTION OF IMMUNOGENICITY
- Publication number 20240075133
- Publication date Mar 7, 2024
- Celgene Corporation
- Jeffrey C. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOP...
- Publication number 20240066026
- Publication date Feb 29, 2024
- Celgene Corporation
- Anjali Agrawal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERI...
- Publication number 20240041894
- Publication date Feb 8, 2024
- Celgene Corporation
- Peter H. Schafer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SIRP-Alpha BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20240034789
- Publication date Feb 1, 2024
- Celgene Corporation
- Mahan Abbasian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC IN...
- Publication number 20240025891
- Publication date Jan 25, 2024
- Celgene Corporation
- Natalie Hawryluk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modulators of BCL6 as Ligand Directed Degraders
- Publication number 20240025851
- Publication date Jan 25, 2024
- Celgene Corporation
- Dehua Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES IN COMBINA...
- Publication number 20240016936
- Publication date Jan 18, 2024
- Celgene Corporation
- Ethan Greene THOMPSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CAR T CELL THERAPY IN PATIENTS WHO HAVE HAD PRIOR ANTI-CANCER ALKYL...
- Publication number 20230398149
- Publication date Dec 14, 2023
- Celgene Corporation
- Julie Ann RYTLEWSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE (R)-5-CARBAMOYLPYRIDIN-3-YL-2-METHYL-4-(3-(TRIFLUOROMET...
- Publication number 20230382861
- Publication date Nov 30, 2023
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY TREATMENT OF LYMPHOID MALIGNANT NEOPLASM CONDIT...
- Publication number 20230365681
- Publication date Nov 16, 2023
- Celgene Corporation
- Haralambos HADJIVASSILIOU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING MULTIPLE MYELOMA AND THE USE OF COMPANION BIOM...
- Publication number 20230341375
- Publication date Oct 26, 2023
- Celgene Corporation
- Maria Soraya Carrancio Anton
- G01 - MEASURING TESTING
Information Patent Application
SOLID FORMS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO...
- Publication number 20230339901
- Publication date Oct 26, 2023
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIPROLIFERATIVE COMPOUNDS AND SECOND ACTIVE AGENTS FOR COMBINED USE
- Publication number 20230330086
- Publication date Oct 19, 2023
- Celgene Corporation
- Lilly L. Wong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DIS...
- Publication number 20230293634
- Publication date Sep 21, 2023
- Celgene Corporation
- Victoria Sung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-...
- Publication number 20230285400
- Publication date Sep 14, 2023
- Celgene Corporation
- Sreenivas S. Bhat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY FOR THE TREATMENT OF CANCER
- Publication number 20230277517
- Publication date Sep 7, 2023
- Celgene Corporation
- Michael D. Amatangelo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING HEMATOLOGICAL MALIGNANCIES USING 2-(2,6-DIOXOPI...
- Publication number 20230277548
- Publication date Sep 7, 2023
- Celgene Corporation
- Maria Soraya Carrancio Anton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-1 Binding Proteins and Methods of Use Thereof
- Publication number 20230272076
- Publication date Aug 31, 2023
- Celgene Corporation
- Brydon Bennett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOP...
- Publication number 20230270742
- Publication date Aug 31, 2023
- Celgene Corporation
- Anjali AGRAWAL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
- Publication number 20230255996
- Publication date Aug 17, 2023
- Celgene Corporation
- Jeffrey B. ETTER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING CANCER WITH COMBINATION THERAPIES
- Publication number 20230255975
- Publication date Aug 17, 2023
- Celgene Corporation
- Aarif AHSAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
- Publication number 20230241086
- Publication date Aug 3, 2023
- Celgene Corporation
- Jeffrey B. ETTER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR THE PREPARATION OF (S)-TERT-BUTYL 4,5-DIAMINO-5-OXOPE...
- Publication number 20230234914
- Publication date Jul 27, 2023
- Celgene Corporation
- John F. Traverse
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1...
- Publication number 20230212137
- Publication date Jul 6, 2023
- Celgene Corporation
- Paul F. Fernandez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CHRONIC LYMPHOCYTIC LEUKEMIA USING 2-(2,6-DIOXO...
- Publication number 20230210859
- Publication date Jul 6, 2023
- Celgene Corporation
- Preethi Janardhanan
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
98519052 - ISBERVIO
- Serial number 98519052
- Filing date Apr 25, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98519044 - MEZNUVIG
- Serial number 98519044
- Filing date Apr 25, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98519051 - HABRINDO
- Serial number 98519051
- Filing date Apr 25, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98473567 - RADURYGO
- Serial number 98473567
- Filing date Mar 28, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98473577 - MYDURIBEK
- Serial number 98473577
- Filing date Mar 28, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98473560 - ONGOZIG
- Serial number 98473560
- Filing date Mar 28, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98473574 - DUOBEQUE
- Serial number 98473574
- Filing date Mar 28, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98473564 - TACELNU
- Serial number 98473564
- Filing date Mar 28, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98445659 - GOLQUIPA
- Serial number 98445659
- Filing date Mar 12, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98435990 - GOLKESDRA
- Serial number 98435990
- Filing date Mar 6, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98435991 - GOLYDVI
- Serial number 98435991
- Filing date Mar 6, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98435992 - LYMZENTY
- Serial number 98435992
- Filing date Mar 6, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98435987 - GOKESDRA
- Serial number 98435987
- Filing date Mar 6, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98435994 - OMGOLVO
- Serial number 98435994
- Filing date Mar 6, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98418207 - CRELBYN
- Serial number 98418207
- Filing date Feb 23, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98418223 - GOLQUIPTY
- Serial number 98418223
- Filing date Feb 23, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98418225 - GOLYMPCA
- Serial number 98418225
- Filing date Feb 23, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98418209 - GOLPEXUS
- Serial number 98418209
- Filing date Feb 23, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98418212 - GOLQEMZI
- Serial number 98418212
- Filing date Feb 23, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98418220 - GOLQUIP
- Serial number 98418220
- Filing date Feb 23, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98418227 - GOLYMPKA
- Serial number 98418227
- Filing date Feb 23, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98418228 - LYMSTARLO
- Serial number 98418228
- Filing date Feb 23, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98397723 - WILBEXUS
- Serial number 98397723
- Filing date Feb 8, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98397734 - LIFCASUS
- Serial number 98397734
- Filing date Feb 8, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98390031 - PEXGOLY
- Serial number 98390031
- Filing date Feb 3, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98390035 - MYRAGOLZ
- Serial number 98390035
- Filing date Feb 3, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98390038 - LYMLITEZ
- Serial number 98390038
- Filing date Feb 3, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98390044 - RYGOLVYN
- Serial number 98390044
- Filing date Feb 3, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98390032 - PANLYMUNA
- Serial number 98390032
- Filing date Feb 3, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98390033 - PANLYMGO
- Serial number 98390033
- Filing date Feb 3, 2024
- Celgene Corporation
- 5 - Pharmaceutical and veterinary preparations

Celgene Corporation

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Transgenic mouse expressing human cereblon

Substituted 4-aminoisoindoline-1,3-dione compounds, compositions th...

Combination therapies using an anti-BCMA antibody drug conjugate (A...

Carboxylic acid containing azetidinyl compounds for the treatment o...

Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxope...

Formulations of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)...

Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds,...

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dio...

T lymphocyte production methods and t lymphocytes produced thereby

Modified T lymphocytes comprising a CD52 antibody-inducible caspase...

Anti-CD47 antibodies and uses thereof

Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxo...

Methods of synthesis of (1R,2R,5R)-5-amino-2-methyl-cyclohexanol hy...

Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoiso...

Cereblon binding compounds, compositions thereof, and methods of tr...

Compositions and methods for inducing conformational changes in cer...

Methods for treating multiple myeloma and the use of companion biom...

Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-...

Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromet...

Methods of treating hematological malignancies using 2-(2,6-dioxopi...

Antiproliferative compounds and second active agents for combined use

3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperi...

Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-pi...

Methods for measuring small molecule affinity to cereblon

Cereblon binding compounds, compositions thereof, and methods of tr...

Methods of treating chronic lymphocytic leukemia using 2-(2,6-dioxo...

Methods of improving vector transduction efficiency into T lymphocytes

Digital health prognostic analyzer for multiple myeloma mortality p...

SIRP-α binding proteins and methods of use thereof

Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2...

Patents Applicationslast 30 patents

SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS A...

Methods for Treating Multiple Myeloma

Carboxylic Acid Containing Indanyl Compounds for the Treatment of N...

Heterocyclic Compounds and Their Use for Parasitic Diseases

Heteroaryl Compounds as Ligand Directed Degraders of IRAK4

METHODS AND COMPOSITIONS FOR REDUCTION OF IMMUNOGENICITY

PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOP...

3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERI...

SIRP-Alpha BINDING PROTEINS AND METHODS OF USE THEREOF

HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC IN...

Modulators of BCL6 as Ligand Directed Degraders

USES OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES IN COMBINA...

CAR T CELL THERAPY IN PATIENTS WHO HAVE HAD PRIOR ANTI-CANCER ALKYL...

CRYSTALLINE (R)-5-CARBAMOYLPYRIDIN-3-YL-2-METHYL-4-(3-(TRIFLUOROMET...

BISPECIFIC ANTIBODY TREATMENT OF LYMPHOID MALIGNANT NEOPLASM CONDIT...

METHODS FOR TREATING MULTIPLE MYELOMA AND THE USE OF COMPANION BIOM...

SOLID FORMS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO...

ANTIPROLIFERATIVE COMPOUNDS AND SECOND ACTIVE AGENTS FOR COMBINED USE

ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DIS...

PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-...

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

METHODS OF TREATING HEMATOLOGICAL MALIGNANCIES USING 2-(2,6-DIOXOPI...

PD-1 Binding Proteins and Methods of Use Thereof

PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOP...

ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF

METHODS FOR TREATING CANCER WITH COMBINATION THERAPIES

ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF

PROCESSES FOR THE PREPARATION OF (S)-TERT-BUTYL 4,5-DIAMINO-5-OXOPE...

SOLID FORMS OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1...

METHODS OF TREATING CHRONIC LYMPHOCYTIC LEUKEMIA USING 2-(2,6-DIOXO...

Trademarklast 30 trademarks

98519052 - ISBERVIO

98519044 - MEZNUVIG

98519051 - HABRINDO

98473567 - RADURYGO

98473577 - MYDURIBEK

98473560 - ONGOZIG

98473574 - DUOBEQUE

98473564 - TACELNU

98445659 - GOLQUIPA

98435990 - GOLKESDRA